Company profile for Innoviva Specialty Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Innoviva Specialty Therapeutics is dedicated to advancing innovative treatments for serious diseases, focusing on oncology and infectious diseases. With a commitment to improving patient outcomes, the company develops a diverse pipeline of novel therapies targeting unmet medical needs. Leveraging expertise in drug development and a patient-centric approach, Innoviva Specialty Therapeutics aims to deliver transformative solutio...
Innoviva Specialty Therapeutics is dedicated to advancing innovative treatments for serious diseases, focusing on oncology and infectious diseases. With a commitment to improving patient outcomes, the company develops a diverse pipeline of novel therapies targeting unmet medical needs. Leveraging expertise in drug development and a patient-centric approach, Innoviva Specialty Therapeutics aims to deliver transformative solutions to healthcare challenges. By addressing critical gaps in treatment, the company strives to make a meaningful impact on patients’ lives worldwide.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
930 Winter Street Suite 1500 Waltham, MA USA 02451
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251125545821/en/Innoviva-to-Participate-in-the-37th-Annual-Piper-Sandler-Healthcare-Conference

BUSINESSWIRE
25 Nov 2025

https://www.pharmiweb.com/press-release/2025-10-20/innoviva-specialty-therapeutics-announces-oral-presentation-featuring-new-analyses-from-the-zoliflod

PHARMIWEB
20 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-07/innoviva-specialty-therapeutics-to-deliver-six-presentations-from-its-infectious-diseases-and-critic

PHARMIWEB
07 Oct 2025

https://www.businesswire.com/news/home/20250813478127/en/Innoviva-Specialty-Therapeutics-Antimicrobial-Therapies-ZEVTERA-and-XACDURO-Nominated-for-the-2025-Prix-Galien-USA-Best-Pharmaceutical-Product-Award

BUSINESSWIRE
13 Aug 2025

https://www.businesswire.com/news/home/20250612432209/en/FDA-Grants-Priority-Review-for-Zoliflodacin-New-Drug-Application-for-the-Treatment-of-Uncomplicated-Gonorrhea-and-Assigns-Target-PDUFA-Date-of-December-15-2025

BUSINESSWIRE
12 Jun 2025

https://www.businesswire.com/news/home/20250610102070/en/Innoviva-Specialty-Therapeutics-Receives-FDA-New-Drug-Application-Acceptance-for-Zoliflodacin-a-First-in-Class-Oral-Antibiotic-for-Uncomplicated-Gonorrhea-in-Adults

BUSINESSWIRE
10 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty